Stoll, F.; Seidel-Glätzer, A.; Burghaus, I.; Göring, O.; Sauter, M.; Rose, P.; Daniel, V.; Haag, M.; Schwab, M.; Riffel, J.;
et al. Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide—An Exploratory Phase I Clinical Trial. Int. J. Mol. Sci. 2022, 23, 15924.
https://doi.org/10.3390/ijms232415924
AMA Style
Stoll F, Seidel-Glätzer A, Burghaus I, Göring O, Sauter M, Rose P, Daniel V, Haag M, Schwab M, Riffel J,
et al. Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide—An Exploratory Phase I Clinical Trial. International Journal of Molecular Sciences. 2022; 23(24):15924.
https://doi.org/10.3390/ijms232415924
Chicago/Turabian Style
Stoll, Felicitas, Andrea Seidel-Glätzer, Ina Burghaus, Oliver Göring, Max Sauter, Peter Rose, Volker Daniel, Mathias Haag, Matthias Schwab, Johannes Riffel,
and et al. 2022. "Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide—An Exploratory Phase I Clinical Trial" International Journal of Molecular Sciences 23, no. 24: 15924.
https://doi.org/10.3390/ijms232415924
APA Style
Stoll, F., Seidel-Glätzer, A., Burghaus, I., Göring, O., Sauter, M., Rose, P., Daniel, V., Haag, M., Schwab, M., Riffel, J., André, F., Taylor, L., Weiss, J., Burhenne, J., Cleeves, V., Haefeli, W. E., & Blank, A.
(2022). Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide—An Exploratory Phase I Clinical Trial. International Journal of Molecular Sciences, 23(24), 15924.
https://doi.org/10.3390/ijms232415924
